8-KThe WireStrategic
Results of Operations · Reg FD Disclosure
Filed May 12, 2026 · 2mo ago · Accession 0001104659-26-059393
Plain English
TELA Bio, Inc. reported its first quarter 2026 financial results and provided an update on its corporate slide deck. The company announced a strategic board refreshment plan and the U.S. commercial launch of OviTex LTR.
Filing details
- Company
- TELA Bio, Inc.
- Ticker
- TELA
- CIK
- 1561921
- Form type
- 8-K
- Filing date
- May 12, 2026
- Report date
- May 12, 2026
- Document
- tm2614218d1_8k.htm
- Size
- 4.9 MB